The Gulf Coast Consortia's Microphysiological Lead Optimization and Toxicity Screening (MLOTS) program helps Texas researchers develop better cancer treatments by giving them fast, affordable access to advanced laboratory testing. Many drug ideas fail because researchers lack early evidence about whether a treatment is likely to work or may cause serious side effects. MLOTS fills this gap with early-stage human-relevant models that show which candidates look promising and which should be improved or set aside. Investigators from universities, medical centers, and drug discovery companies across Texas send new cancer drug candidates to MLOTS. Using tumor models like tiny three-dimensional min...
Read More
The Gulf Coast Consortia's Microphysiological Lead Optimization and Toxicity Screening (MLOTS) program helps Texas researchers develop better cancer treatments by giving them fast, affordable access to advanced laboratory testing. Many drug ideas fail because researchers lack early evidence about whether a treatment is likely to work or may cause serious side effects. MLOTS fills this gap with early-stage human-relevant models that show which candidates look promising and which should be improved or set aside. Investigators from universities, medical centers, and drug discovery companies across Texas send new cancer drug candidates to MLOTS. Using tumor models like tiny three-dimensional mini-tumors called spheroids and organoids, the core tests whether the drug candidates stop cancer cell growth or kill the cancer cells in conditions that resemble human tissues. At the same time, MLOTS checks for early safety concerns using human-cell systems for the heart, brain, and liver, focusing on problems-such as abnormal heart rhythms, unwanted nerve activity, or liver injury-that often derail drugs later in development. MLOTS provides all data to the teams so that our "fail-early, decide-with-evidence" approach helps them avoid costly dead ends, reduces animal use, and focuses them on the most promising treatments. The renewed program keeps these proven services and adds carefully selected human-focused methods that national agencies are encouraging to make research more relevant to patients. Simple data-science tools being added assist interpretation and help guide smart refinements before animal studies. MLOTS also trains students and post-doctoral fellows through hands-on participation in real projects. By combining human-relevant models, early safety screening, practical data tools, and workforce training, MLOTS speeds the path from scientific ideas to potential cancer therapies for Texans.
Read Less
